Your browser doesn't support javascript.
loading
CD73 Promotes Resistance to HER2/ErbB2 Antibody Therapy.
Turcotte, Martin; Allard, David; Mittal, Deepak; Bareche, Yacine; Buisseret, Laurence; José, Vinu; Pommey, Sandra; Delisle, Vincent; Loi, Sherene; Joensuu, Heikki; Kellokumpu-Lehtinen, Pirkko-Liisa; Sotiriou, Christos; Smyth, Mark J; Stagg, John.
Afiliação
  • Turcotte M; Centre de Recherche du Centre Hospitalier de l'Université de Montréal, Québec, Canada.
  • Allard D; Institut du Cancer de Montréal, Montréal, Québec, Canada.
  • Mittal D; Faculté de Pharmacie, Université de Montréal, Québec, Canada.
  • Bareche Y; Centre de Recherche du Centre Hospitalier de l'Université de Montréal, Québec, Canada.
  • Buisseret L; Institut du Cancer de Montréal, Montréal, Québec, Canada.
  • José V; Faculté de Pharmacie, Université de Montréal, Québec, Canada.
  • Pommey S; Immunology in Cancer and Infection Laboratory, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia.
  • Delisle V; School of Medicine, University of Queensland, Herston, Queensland, Australia.
  • Loi S; Molecular Immunology Unit, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium.
  • Joensuu H; Breast Cancer Translational Research Laboratory J.-C. Heuson, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium.
  • Kellokumpu-Lehtinen PL; Molecular Immunology Unit, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium.
  • Sotiriou C; Breast Cancer Translational Research Laboratory J.-C. Heuson, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium.
  • Smyth MJ; Molecular Immunology Unit, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium.
  • Stagg J; Breast Cancer Translational Research Laboratory J.-C. Heuson, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium.
Cancer Res ; 77(20): 5652-5663, 2017 10 15.
Article em En | MEDLINE | ID: mdl-28855210
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Antígenos CD / 5'-Nucleotidase / Receptor ErbB-2 / Tetraspaninas / Anticorpos Monoclonais / Antígenos de Neoplasias Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Animals / Female / Humans Idioma: En Revista: Cancer Res Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Canadá
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Antígenos CD / 5'-Nucleotidase / Receptor ErbB-2 / Tetraspaninas / Anticorpos Monoclonais / Antígenos de Neoplasias Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Animals / Female / Humans Idioma: En Revista: Cancer Res Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Canadá